Application 022567
- Type
- NDA
- Sponsor
- ALLERGAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VIIBRYD | VILAZODONE HYDROCHLORIDE | TABLET;ORAL | 10MG | Yes | Yes |
| 002 | VIIBRYD | VILAZODONE HYDROCHLORIDE | TABLET;ORAL | 20MG | Yes | No |
| 003 | VIIBRYD | VILAZODONE HYDROCHLORIDE | TABLET;ORAL | 40MG | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022567-001 | VIIBRYD | VILAZODONE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | RLD, RS | 2011-01-21 |
| N022567-002 | VIIBRYD | VILAZODONE HYDROCHLORIDE | 20MG | TABLET / ORAL | AB | RLD | 2011-01-21 |
| N022567-003 | VIIBRYD | VILAZODONE HYDROCHLORIDE | 40MG | TABLET / ORAL | AB | RLD | 2011-01-21 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N022567-001 | AB |
| N022567-002 | AB |
| N022567-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022567-001 | VIIBRYD | 10MG | TABLET / ORAL | AB | RLD, RS | 2011-01-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022567-002 | VIIBRYD | 20MG | TABLET / ORAL | AB | RLD | 2011-01-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022567-003 | VIIBRYD | 40MG | TABLET / ORAL | AB | RLD | 2011-01-21 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N022567-001 | VIIBRYD | 10MG | TABLET / ORAL | AB | RLD, RS | 2011-01-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022567-002 | VIIBRYD | 20MG | TABLET / ORAL | AB | RLD | 2011-01-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022567-003 | VIIBRYD | 40MG | TABLET / ORAL | AB | RLD | 2011-01-21 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N022567-001 | VIIBRYD | 10MG | TABLET / ORAL | AB | RLD, RS | 2011-01-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022567-002 | VIIBRYD | 20MG | TABLET / ORAL | AB | RLD | 2011-01-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022567-003 | VIIBRYD | 40MG | TABLET / ORAL | AB | RLD | 2011-01-21 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022567-001 | VIIBRYD | 10MG | TABLET / ORAL | AB | RLD, RS | 2011-01-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022567-002 | VIIBRYD | 20MG | TABLET / ORAL | AB | RLD | 2011-01-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022567-003 | VIIBRYD | 40MG | TABLET / ORAL | AB | RLD | 2011-01-21 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N022567-001 | VIIBRYD | 10MG | TABLET / ORAL | AB | RLD, RS | 2011-01-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022567-002 | VIIBRYD | 20MG | TABLET / ORAL | AB | RLD | 2011-01-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022567-003 | VIIBRYD | 40MG | TABLET / ORAL | AB | RLD | 2011-01-21 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022567-001 | VIIBRYD | 10MG | TABLET / ORAL | AB | RLD, RS | 2011-01-21 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022567-002 | VIIBRYD | 20MG | TABLET / ORAL | AB | RLD | 2011-01-21 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022567-003 | VIIBRYD | 40MG | TABLET / ORAL | AB | RLD | 2011-01-21 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022567-001 | VIIBRYD | 10MG | TABLET / ORAL | AB | RLD, RS | 2011-01-21 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022567-002 | VIIBRYD | 20MG | TABLET / ORAL | AB | RLD | 2011-01-21 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022567-003 | VIIBRYD | 40MG | TABLET / ORAL | AB | RLD | 2011-01-21 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022567-001 | VIIBRYD | 10MG | TABLET / ORAL | AB | RLD, RS | 2011-01-21 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022567-002 | VIIBRYD | 20MG | TABLET / ORAL | AB | RLD | 2011-01-21 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022567-003 | VIIBRYD | 40MG | TABLET / ORAL | AB | RLD | 2011-01-21 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022567-001 | VIIBRYD | 10MG | TABLET / ORAL | AB | RLD, RS | 2011-01-21 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022567-002 | VIIBRYD | 20MG | TABLET / ORAL | AB | RLD | 2011-01-21 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022567-003 | VIIBRYD | 40MG | TABLET / ORAL | AB | RLD | 2011-01-21 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022567-001 | VIIBRYD | 10MG | TABLET / ORAL | AB | RLD, RS | 2011-01-21 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022567-002 | VIIBRYD | 20MG | TABLET / ORAL | AB | RLD | 2011-01-21 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022567-003 | VIIBRYD | 40MG | TABLET / ORAL | AB | RLD | 2011-01-21 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022567-001 | VIIBRYD | 10MG | TABLET / ORAL | AB | RLD, RS | 2011-01-21 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022567-002 | VIIBRYD | 20MG | TABLET / ORAL | AB | RLD | 2011-01-21 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022567-003 | VIIBRYD | 40MG | TABLET / ORAL | AB | RLD | 2011-01-21 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N022567-001 | VIIBRYD | 10MG | TABLET / ORAL | AB | RLD, RS | 2011-01-21 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N022567-002 | VIIBRYD | 20MG | TABLET / ORAL | AB | RLD | 2011-01-21 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N022567-003 | VIIBRYD | 40MG | TABLET / ORAL | AB | RLD | 2011-01-21 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022567-001 | VIIBRYD | 10MG | TABLET / ORAL | AB | RLD, RS | 2011-01-21 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022567-002 | VIIBRYD | 20MG | TABLET / ORAL | AB | RLD | 2011-01-21 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022567-003 | VIIBRYD | 40MG | TABLET / ORAL | AB | RLD | 2011-01-21 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022567-001 | VIIBRYD | 10MG | TABLET / ORAL | AB | RLD, RS | 2011-01-21 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022567-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022567-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022567-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N022567-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022567-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022567-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N022567-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022567-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022567-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022567-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022567-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022567-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N022567-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022567-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022567-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022567-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022567-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022567-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022567-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022567-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022567-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022567-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022567-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022567-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022567-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022567-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022567-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022567-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022567-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022567-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022567-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022567-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022567-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N022567-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N022567-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N022567-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022567-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022567-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022567-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022567-001 | AB | 1 | 301d65b070ca… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-001 | 7834020 | 2022-06-05 | U-839 | Drug substance, Drug product | 2011-01-25 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-001 | 8193195 | 2022-06-05 | U-839 | 2012-06-14 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-001 | 8236804 | 2022-06-05 | U-839 | 2012-08-14 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-001 | 8673921 | 2022-06-05 | Drug substance, Drug product | 2014-03-21 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-001 | 7834020*PED | 2022-12-05 | Pediatric extension | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-001 | 8193195*PED | 2022-12-05 | Pediatric extension | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-001 | 8236804*PED | 2022-12-05 | Pediatric extension | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-001 | 8673921*PED | 2022-12-05 | Pediatric extension | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-002 | 7834020 | 2022-06-05 | U-839 | Drug substance, Drug product | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-002 | 8193195 | 2022-06-05 | U-839 | 2012-06-14 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-002 | 8236804 | 2022-06-05 | U-839 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-002 | 8673921 | 2022-06-05 | Drug substance, Drug product | 2014-03-21 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-002 | 7834020*PED | 2022-12-05 | Pediatric extension | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-002 | 8193195*PED | 2022-12-05 | Pediatric extension | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-002 | 8236804*PED | 2022-12-05 | Pediatric extension | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-002 | 8673921*PED | 2022-12-05 | Pediatric extension | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-003 | 7834020 | 2022-06-05 | U-839 | Drug substance, Drug product | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-003 | 8193195 | 2022-06-05 | U-839 | 2012-06-14 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-003 | 8236804 | 2022-06-05 | U-839 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-003 | 8673921 | 2022-06-05 | Drug substance, Drug product | 2014-03-21 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-003 | 7834020*PED | 2022-12-05 | Pediatric extension | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-003 | 8193195*PED | 2022-12-05 | Pediatric extension | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-003 | 8236804*PED | 2022-12-05 | Pediatric extension | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-003 | 8673921*PED | 2022-12-05 | Pediatric extension | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N022567-001 | 7834020 | 2022-06-05 | U-839 | Drug substance, Drug product | 2011-01-25 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N022567-001 | 8193195 | 2022-06-05 | U-839 | 2012-06-14 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022567-001 | 8236804 | 2022-06-05 | U-839 | 2012-08-14 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022567-001 | 8673921 | 2022-06-05 | Drug substance, Drug product | 2014-03-21 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022567-001 | 7834020*PED | 2022-12-05 | Pediatric extension | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N022567-001 | 8193195*PED | 2022-12-05 | Pediatric extension | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N022567-001 | 8236804*PED | 2022-12-05 | Pediatric extension | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N022567-001 | 8673921*PED | 2022-12-05 | Pediatric extension | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N022567-002 | 7834020 | 2022-06-05 | U-839 | Drug substance, Drug product | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022567-002 | 8193195 | 2022-06-05 | U-839 | 2012-06-14 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022567-002 | 8236804 | 2022-06-05 | U-839 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N022567-002 | 8673921 | 2022-06-05 | Drug substance, Drug product | 2014-03-21 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022567-002 | 7834020*PED | 2022-12-05 | Pediatric extension | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N022567-002 | 8193195*PED | 2022-12-05 | Pediatric extension | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N022567-002 | 8236804*PED | 2022-12-05 | Pediatric extension | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N022567-002 | 8673921*PED | 2022-12-05 | Pediatric extension | 5d02ea3f76ae… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-001 | M-254 | 2023-01-31 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-001 | PED | 2023-07-31 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-002 | M-254 | 2023-01-31 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-002 | PED | 2023-07-31 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-003 | M-254 | 2023-01-31 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022567-003 | PED | 2023-07-31 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N022567-001 | M-254 | 2023-01-31 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N022567-001 | PED | 2023-07-31 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N022567-002 | M-254 | 2023-01-31 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N022567-002 | PED | 2023-07-31 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N022567-003 | M-254 | 2023-01-31 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N022567-003 | PED | 2023-07-31 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N022567-001 | M-254 | 2023-01-31 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N022567-001 | PED | 2023-07-31 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N022567-002 | M-254 | 2023-01-31 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N022567-002 | PED | 2023-07-31 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N022567-003 | M-254 | 2023-01-31 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N022567-003 | PED | 2023-07-31 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | N022567-001 | M-254 | 2023-01-31 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N022567-001 | PED | 2023-07-31 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N022567-002 | M-254 | 2023-01-31 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N022567-002 | PED | 2023-07-31 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N022567-003 | M-254 | 2023-01-31 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N022567-003 | PED | 2023-07-31 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N022567-001 | M-254 | 2023-01-31 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N022567-001 | PED | 2023-07-31 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N022567-002 | M-254 | 2023-01-31 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N022567-002 | PED | 2023-07-31 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N022567-003 | M-254 | 2023-01-31 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N022567-003 | PED | 2023-07-31 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022567-001 | M-254 | 2023-01-31 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022567-001 | PED | 2023-07-31 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022567-002 | M-254 | 2023-01-31 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022567-002 | PED | 2023-07-31 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022567-003 | M-254 | 2023-01-31 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022567-003 | PED | 2023-07-31 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N022567-001 | M-254 | 2023-01-31 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N022567-001 | PED | 2023-07-31 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N022567-002 | M-254 | 2023-01-31 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N022567-002 | PED | 2023-07-31 | 5aa47cf7b7d7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VIIBRYD | VILAZODONE HYDROCHLORIDE | Allergan, Inc. | 4c55ccfb-c4cf-11df-851a-0800200c9a66 | 2023-10-01 | Boxed warning, Warnings, Adverse reactions | 022567 NDA022567 0456-1101 0456-1140 0456-1110 0456-1120 0456-1100 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0456-1100 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1100 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1100 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1100 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1100 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1100 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1101 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1101 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1101 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1101 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1101 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1101 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1110 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1110 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1110 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1110 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1110 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1110 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1120 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1120 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1120 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1120 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1120 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1120 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1140 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1140 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1140 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1140 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1140 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1140 | VIIBRYD | vilazodone hydrochloride | Allergan, Inc. | NDA | Current |
| 51407-691 | vilazodone | vilazodone hydrochloride | Golden State Medical Supply, Inc. | NDA AUTHORIZED GENERIC | Current |
| 51407-692 | Vilazodone | vilazodone hydrochloride | Golden State Medical Supply, Inc. | NDA AUTHORIZED GENERIC | Current |
| 51407-693 | Vilazodone | vilazodone hydrochloride | Golden State Medical Supply, Inc. | NDA AUTHORIZED GENERIC | Current |
| 55154-4624 | VIIBRYD | vilazodone hydrochloride | Cardinal Health 107, LLC | NDA | Current |
| 55154-4624 | VIIBRYD | vilazodone hydrochloride | Cardinal Health | NDA | Current |
| 55154-4624 | VIIBRYD | vilazodone hydrochloride | Cardinal Health | NDA | Current |
| 55154-4624 | VIIBRYD | vilazodone hydrochloride | Cardinal Health | NDA | Current |
| 55154-4627 | VIIBRYD | vilazodone hydrochloride | Cardinal Health 107, LLC | NDA | Current |
| 55154-4627 | VIIBRYD | vilazodone hydrochloride | Cardinal Health | NDA | Current |
| 55154-4627 | VIIBRYD | vilazodone hydrochloride | Cardinal Health | NDA | Current |
| 55154-4627 | VIIBRYD | vilazodone hydrochloride | Cardinal Health | NDA | Current |
| 60505-4772 | vilazodone | vilazodone hydrochloride | Apotex Corp | NDA AUTHORIZED GENERIC | Current |
| 60505-4773 | Vilazodone | vilazodone hydrochloride | Apotex Corp | NDA AUTHORIZED GENERIC | Current |
| 60505-4774 | Vilazodone | vilazodone hydrochloride | Apotex Corp | NDA AUTHORIZED GENERIC | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 78265 | SUPPL | 2024-04-25 |
| 78229 | SUPPL | 2024-04-24 |
| 78200 | SUPPL | 2024-04-22 |
| 75243 | SUPPL | 2023-08-22 |
| 75177 | SUPPL | 2023-08-21 |
| 68772 | SUPPL | 2021-09-24 |
| 68771 | SUPPL | 2021-09-24 |
| 68724 | SUPPL | 2021-09-22 |
| 61763 | SUPPL | 2020-02-04 |
| 61756 | SUPPL | 2020-02-03 |
| 61755 | SUPPL | 2020-02-03 |
| 46786 | SUPPL | 2017-01-11 |
| 46785 | SUPPL | 2017-01-11 |
| 46680 | SUPPL | 2017-01-06 |
| 45275 | SUPPL | 2016-09-08 |
| 45244 | SUPPL | 2016-09-06 |
| 7539 | SUPPL | 2015-04-02 |
| 17717 | SUPPL | 2015-03-19 |
| 17718 | SUPPL | 2014-07-17 |
| 7540 | SUPPL | 2014-07-17 |
| 29865 | SUPPL | 2014-04-09 |
| 17716 | SUPPL | 2014-04-08 |
| 17715 | SUPPL | 2013-12-19 |
| 7538 | SUPPL | 2013-12-19 |
| 17714 | SUPPL | 2013-01-11 |
| 29864 | SUPPL | 2012-12-26 |
| 23713 | ORIG | 2012-02-13 |
| 17713 | SUPPL | 2011-09-23 |
| 7536 | SUPPL | 2011-09-23 |
| 7537 | SUPPL | 2011-07-06 |
| 24342 | ORIG | 2011-03-01 |
| 22059 | ORIG | 2011-03-01 |
| 7535 | ORIG | 2011-01-26 |
| 38842 | ORIG | 2011-01-24 |
| 64950 | ORIG | 1900-01-01 |
| 63981 | ORIG | 1900-01-01 |
| 63980 | ORIG | 1900-01-01 |